EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Clinical trials for EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) trials appear
Sign up with your email to follow new studies for EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new treatment for rare vasculitis shows potential to reduce steroid dependence
Disease control CompletedThis study tested whether a drug called rituximab, combined with standard steroids, works better than the usual treatment for a rare disease called EGPA, which causes inflammation of small blood vessels. 107 adults with newly diagnosed or relapsing EGPA took part. The goal was to…
Matched conditions: EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Could a low-dose alcoholism drug ease vasculitis symptoms?
Symptom relief CompletedThis study tested whether a very low dose of naltrexone, a drug normally used for alcoholism, can improve physical health and quality of life in people with vasculitis (a group of rare blood vessel diseases). Sixty adults with different types of vasculitis took either the low-dos…
Matched conditions: EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated May 17, 2026 08:20 UTC